:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/cmg/RSTH3QEQZTDCBG7EERTSLPHNBI.jpg)
The new drug is said to be able to find and treat cancer cells while not harming healthy ones. Kadcyla is a combination of Herceptin and a chemo drug as well a chemical binding agent. The chemical allows the drugs to be delivered to the cancer cells, thereby hitting the cancer with a medical double whammy.
The drug was developed by Roche’s Genentech unit.
The drawback at this point is cost, the new drug is said to cost up to $10,000 per month and is only approved for a fifth of patients.
:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/cmg/BY5Q5EUP55A3NBU6AQNWFJQCO4.jpg)
Sign Up
